Page 95 | Certara

Press Release

Certara to Report Fourth Quarter and Full Year 2023 Financial Results on February 29th, 2024 and Participate in the Barclays 26th Annual Global Healthcare Conference

PRINCETON, N.J., Feb. 01, 2024 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader…

CertaraFebruary 1, 2024

Conference

Phuse US Connect 2026

– -

CertaraJanuary 31, 2024

On-Demand Webinar

Navigating the “Patent Cliff”: Omni-channel Strategies for Loss of Exclusivity and Established Products

Join us to understand the dynamics of the pharmaceutical market and learn how to maintain…

CertaraJanuary 24, 2024

Blog

Understanding the Role of Your Discovery Asset’s Target Product Profile

If you work at a biotechnology start-up, you’re probably excited about your compound assets, particularly…

CertaraJanuary 19, 2024

On-Demand Webinar

Streamlining Your NCA Workflow

PK analysis intended for submission contends with many data and compliance challenges. To work efficiently,…

CertaraJanuary 18, 2024

Publication

Treatment patterns of patients with HR+/HER2- metastatic breast cancer receiving CDK4/6 inhibitor-based regimens: a cohort study in the French nationwide healthcare database

To assess real-world treatment patterns in patients diagnosed with hormone receptor positive (HR+), human epidermal…

CertaraJanuary 17, 2024

On-Demand Webinar

Clinical Data Standardization: Achieving Cleaner Data and Faster Regulatory Submissions

Master the essentials of clinical data standardization for regulatory submissions in this best practice webinar:…

CertaraJanuary 16, 2024

Publication

Real-world application of PBPK in drug discovery

The utility of PBPK models in support of drug development has been well documented. During…

CertaraJanuary 11, 2024

On-Demand Webinar

Industrializing Quantitative Systems Pharmacology (QSP): Why now and how.

What does it take to industrialize QSP? What is the right mix of technology and…

CertaraJanuary 9, 2024

Fact Sheet

Moving from Molecule to Market

CertaraJanuary 5, 2024

Certara to Report Fourth Quarter and Full Year 2023 Financial Results on February 29th, 2024 and Participate in the Barclays 26th Annual Global Healthcare Conference

Phuse US Connect 2026

Navigating the “Patent Cliff”: Omni-channel Strategies for Loss of Exclusivity and Established Products

Understanding the Role of Your Discovery Asset’s Target Product Profile

Streamlining Your NCA Workflow

Treatment patterns of patients with HR+/HER2- metastatic breast cancer receiving CDK4/6 inhibitor-based regimens: a cohort study in the French nationwide healthcare database

Clinical Data Standardization: Achieving Cleaner Data and Faster Regulatory Submissions

Real-world application of PBPK in drug discovery

Industrializing Quantitative Systems Pharmacology (QSP): Why now and how.

Moving from Molecule to Market

Newsletter sign up

Quick links

Solutions

Contact